Spiro Almotriptan
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

1309457-18-8Spiro Almotriptan

● Under Development

Catalogue No.:VL264011
CAS No.:1309457-18-8
Mol. Formula:C17H25N3O3S
Mol. Weight:351.47 g/mol

Additional information on CAS 1309457-18-8

Parent drug

Almotriptan

IUPAC Name

1′-Methyl-5-((pyrrolidin-1-ylsulfonyl)methyl)spiro[indoline-3, 3′-pyrrolidin]-2-ol

Pharmacopoeial Synonyms

N/A

Other Synonyms

1,2-Dihydro-1′-methyl-5-((1-pyrrolidinylsulfonyl)methyl)spiro(3H-indole-3,3′-pyrrolidin)-2-ol; Spiro(3H-indole-3,3′-pyrrolidin)-2-ol, 1,2-dihydro-1′-methyl-5-((1-pyrrolidinylsulfonyl)methyl)-

Smile

CN1CCC2(C1)C(NC3=C2C=C(C=C3)CS(=O)(=O)N4CCCC4)O

InChI

InChI=1S/C17H25N3O3S/c1-19-9-6-17(12-19)14-10-13(4-5-15(14)18-16(17)21)11-24(22,23)20-7-2-3-8-20/h4-5,10,16,18,21H,2-3,6-9,11-12H2,1H3

Description

Spiro Almotriptan, also known as 1,2-Dihydro-1′-methyl-5-((1-pyrrolidinylsulfonyl)methyl)spiro(3H-indole-3,3′-pyrrolidin)-2-ol; Spiro(3H-indole-3,3′-pyrrolidin)-2-ol, 1,2-dihydro-1′-methyl-5-((1-pyrrolidinylsulfonyl)methyl)-, is a highly characterized reference material. It fully complies with stringent regulatory standards, including those set by USP, EMA, JP, and BP. This product is essential for use in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial production of Almotriptan. Moreover, it comes with a detailed Structure Elucidation Report (SER), ensuring its accuracy and reliability for a wide range of analytical applications. Spiro Almotriptan or 1′-Methyl-5-((pyrrolidin-1-ylsulfonyl)methyl)spiro[indoline-3,3′-pyrrolidin]-2-ol, is a potent and selective 5-HT(1B/1D) receptor agonist,oral administration is approximately 70%, used in the treatment of migraine headaches.

References

Sandrini, Giorgio, et al. “Almotriptan in the Treatment of Migraine.” Neuropsychiatric Disease and Treatment, vol. 3, no. 6, 1 Dec. 2007, pp. 799–809, www.ncbi.nlm.nih.gov/pmc/articles/PMC2656322/.

Request a Quote

« * » indique les champs nécessaires

Ce champ n’est utilisé qu’à des fins de validation et devrait rester inchangé.
Products quotation
Name
Url